Lys9 for Glu9 substitution in glucagon-like peptide-1(7-36)amide confers dipeptidylpeptidase IV resistance with cellular and metabolic actions similar to those of established antagonists glucagon-like peptide-1(9-36)amide and exendin (9-39).

Research output: Contribution to journalArticlepeer-review

37 Citations (Scopus)
Original languageEnglish
Pages (from-to)252-259
Number of pages8
Issue number2
Publication statusPublished - Feb 2004

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this